Ambition, clearly qualified.
How this website distinguishes physical milestones, research activities and conditional commercial projections.
Evidence date and provenance
Research status is based on the Howe Invest WA Battery Summit presentation dated 29 October 2026, the October 2026 corporate profile, and the historical Howetika Clean Edge founder and investor pitch materials. These are company-supplied sources. The website does not independently authenticate the underlying synthesis certificate or research agreements.
Physical synthesis
Peptide manufacture through Auspep and 94% supplier-reported purity against a 90% specification are recorded in company materials. Purity does not establish electrolyte performance or a functioning battery.
Independent research
The company reports an active ECU Research Collaboration Agreement and approved risk assessment. This describes research governance and readiness, not successful experimental outcomes. No completed independent performance dataset is represented. ECU’s researcher profile corroborates Dr Azhar’s affiliation; it does not validate BSSF or the company’s economic model.
Commercial scenarios
All cost differences, future applications and commercial pathways are conditional. The A$2.19 billion annual scenario concerns potential manufacturer value at 100 GWh, not Howe Invest revenue. The detailed assumptions appear on the investor page. No guaranteed savings, returns, grants, offtake or commercial adoption are claimed.
Platform and relationships
Āltika Biotech is owned by Howe Invest Pty Ltd and is presented as a research platform, not a separate legal entity. Historical source materials use the earlier Howetika name. References to ECU and Auspep describe their stated roles and do not imply endorsement of commercial claims. Exploratory research tools and programmes are not validated commercial products.
Confidential information
Technical sequences, formulations, process recipes, unpublished datasets and private agreements are not published here. Access to further information is subject to appropriate company review and confidentiality arrangements.
Updates
New results should be published only after their scope, method, limitations and release status have been reviewed. Contact admin@howeinvest.com for current information.